Nuessler V - Search Results

1

Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives-a meeting report.

Pinto C, Bergmann M, Briukhovetska D, Nuessler V, Sznol M, von Bergwelt-Baildon M, Kobold S. Pinto C, et al. Among authors: nuessler v. J Immunother Cancer. 2020 Feb;8(1):e000268. doi: 10.1136/jitc-2019-000268. J Immunother Cancer. 2020. PMID: 32114499 Free PMC article.

2

Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.

Kufner S, Zitzelsberger H, Kroell T, Pelka-Fleischer R, Salem A, de Valle F, Schweiger C, Nuessler V, Schmid C, Kolb HJ, Schmetzer HM. Kufner S, et al. Among authors: nuessler v. Scand J Immunol. 2005 Jul;62(1):86-98. doi: 10.1111/j.1365-3083.2005.01630.x. Scand J Immunol. 2005. PMID: 16091128 Free article.

3

Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.

Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Nuessler V, Schmetzer H. Graf M, et al. Among authors: nuessler v. Eur J Haematol. 2003 Nov;71(5):366-76. doi: 10.1034/j.1600-0609.2003.00140.x. Eur J Haematol. 2003. PMID: 14667200

4

Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.

Graf M, Reif S, Hecht K, Kroell T, Nuessler V, Schmetzer H. Graf M, et al. Among authors: nuessler v. Eur J Haematol. 2005 Dec;75(6):477-84. doi: 10.1111/j.1600-0609.2005.00539.x. Eur J Haematol. 2005. PMID: 16313259

5

Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.

Graf M, Reif S, Kröll T, Hecht K, Nuessler V, Schmetzer H. Graf M, et al. Among authors: nuessler v. Am J Hematol. 2006 Apr;81(4):227-35. doi: 10.1002/ajh.20526. Am J Hematol. 2006. PMID: 16550517 Free article. Clinical Trial.

6

Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.

Salih HR, Schmetzer HM, Burke C, Starling GC, Dunn R, Pelka-Fleischer R, Nuessler V, Kiener PA. Salih HR, et al. Among authors: nuessler v. J Immunol. 2001 Oct 1;167(7):4059-66. doi: 10.4049/jimmunol.167.7.4059. J Immunol. 2001. PMID: 11564827

7

Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients.

Nuessler V, Gullis E, Pelka-Fleischer R, del Valle F, Diem H, Beyerlein S, Zwierzina H, Wilmanns W. Nuessler V, et al. Ann Hematol. 1997 Jul-Aug;75(1-2):17-26. doi: 10.1007/s002770050307. Ann Hematol. 1997. PMID: 9322679

8

Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.

Nuessler V, Stötzer O, Gullis E, Pelka-Fleischer R, Pogrebniak A, Gieseler F, Wilmanns W. Nuessler V, et al. Leukemia. 1999 Nov;13(11):1864-72. doi: 10.1038/sj.leu.2401571. Leukemia. 1999. PMID: 10557064

9

Cytoprotective features of selenazofurin in hematopoietic cells.

Pogrebniak A, Hasmann M, Schemainda I, Pelka-Fleischer R, Nuessler V. Pogrebniak A, et al. Among authors: nuessler v. Int J Clin Pharmacol Ther. 2002 Aug;40(8):368-75. doi: 10.5414/cpp40368. Int J Clin Pharmacol Ther. 2002. PMID: 12467305

10

Effects of progesterone and leukotriene receptor antagonists in experimental models of P-glycoprotein-related resistance.

Nuessler V, Pelka-Fleischer R, Zwierzina H, Wilmanns W, Denzlinger C. Nuessler V, et al. Eur J Med Res. 1997 Apr 21;2(4):159-64. Eur J Med Res. 1997. PMID: 9110922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page